Novo Nordisk
NVO
NVO
525 hedge funds and large institutions have $11B invested in Novo Nordisk in 2015 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 183 increasing their positions, 187 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
525
Holders Change
+9
Holders Change %
+1.74%
% of All Funds
14.67%
Holding in Top 10
32
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+3.23%
% of All Funds
0.89%
New
48
Increased
183
Reduced
187
Closed
36
Calls
$9.93M
Puts
$24.5M
Net Calls
-$14.5M
Net Calls Change
-$20.1M
Top Buyers
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$287M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$96.3M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$60.7M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$52.7M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$25.8M |
Top Sellers
| 1 |
Jennison Associates
New York
|
-$88.8M |
| 2 |
JSP
Jackson Square Partners
Larkspur,
California
|
-$82.1M |
| 3 |
Renaissance Technologies
New York
|
-$49.7M |
| 4 |
Fisher Asset Management
Camas,
Washington
|
-$34.9M |
| 5 |
Bank of New York Mellon
New York
|
-$30.9M |
